Improvement of Insulin Resistance and Reduction of Cardiovascular Risk Among Obese Patients with Type 2 Diabetes with the Duodenojejunal Bypass Liner
about
Prediction of glycated hemoglobin levels at 3 months after metabolic surgery based on the 7-day plasma metabolic profileMetabolic surgery and intestinal gene expression: Digestive tract and diabetes evolution considerations.The duodenal-jejunal bypass liner for the treatment of type 2 diabetes mellitus and/or obesity: a systematic review.Duodenal-jejunal bypass liner to treat type 2 diabetes mellitus in morbidly obese patients.Bariatric surgery--an update for the endocrinologist.Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis.Surgical cure for type 2 diabetes by foregut or hindgut operations: a myth or reality? A systematic review.Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients.Effects of duodeno-jejunal bypass on glucose metabolism in obese rats with type 2 diabetes.Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study.Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients.The feasibility of delivering a duodenal-jejunal bypass liner (EndoBarrier) endoscopically with patients under conscious sedation.Impact of Duodenal-Jejunal Exclusion on Satiety Hormones.
P2860
Q28544823-72683C34-933A-4237-9C7E-1D4F817FECF1Q35716332-3D6915E3-D0EF-4A19-94CF-06C293BCA728Q38167689-2ED52DFD-3398-40EE-804A-1F184D8F76E4Q38191195-B591B87A-C430-4A22-9DFD-2848258E4BF5Q38334618-6D2FCDBD-8DC2-418C-9AD0-23792E481468Q38625348-29655AD4-4825-4D51-A9F9-E53F5A0DFADEQ38837956-1E114C47-25E2-4596-8435-FAAED42D5A3AQ45833015-0B67C126-06F0-4506-9113-91651C62B884Q46421754-B71A7D01-D6BC-4AC5-8994-715AB136126AQ47261100-A8E2A283-923E-4A34-9816-2261D3AFCA14Q47581286-8B61B083-6BB6-4CEF-902C-F61AAB113274Q47977411-D19084B5-08C7-4B5E-844D-0F646449F993Q50560792-86A6F6C2-B6A3-42C6-BDBB-DB640111C514
P2860
Improvement of Insulin Resistance and Reduction of Cardiovascular Risk Among Obese Patients with Type 2 Diabetes with the Duodenojejunal Bypass Liner
description
scientific article published on 01 July 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2011
@uk
name
Improvement of Insulin Resista ...... he Duodenojejunal Bypass Liner
@en
Improvement of Insulin Resista ...... he Duodenojejunal Bypass Liner
@nl
type
label
Improvement of Insulin Resista ...... he Duodenojejunal Bypass Liner
@en
Improvement of Insulin Resista ...... he Duodenojejunal Bypass Liner
@nl
prefLabel
Improvement of Insulin Resista ...... he Duodenojejunal Bypass Liner
@en
Improvement of Insulin Resista ...... he Duodenojejunal Bypass Liner
@nl
P2093
P2860
P921
P1433
P1476
Improvement of insulin resista ...... he duodenojejunal bypass liner
@en
P2093
Alfredo Halpern
Almino Cardoso Ramos
Arthur Belarmino Garrido-Júnior
Bruno da Costa Martins
Eduardo Guimarães Hourneaux de Moura
Guilherme Sauniti Lopes
Ivan Roberto Bonotto Orso
Manoel dos Passos Galvão-Neto
Marcio Correa Mancini
Marco Aurélio Santo
P2860
P2888
P304
P356
10.1007/S11695-011-0387-0
P577
2011-07-01T00:00:00Z